The neoplasms mortality rate among females in Canada is projected to steadily increase from 39.78 thousand deaths in 2024 to 40.85 thousand in 2028. Comparing this with the 2023 value of approximately 39.51 thousand, we see an upward trajectory with notable year-on-year increases. Specifically, from 2024 to 2025, the forecast shows a rise of about 0.68%, and similarly, each subsequent year reflects a rise of approximately 0.68%, signaling consistent growth. The compound annual growth rate (CAGR) over the five-year period highlights an average annual increase in mortality rate.
Future trends to watch include advancements in medical technology and healthcare access, which could impact this mortality rate. Additionally, population aging and lifestyle changes may further influence trends, offering areas of opportunity for interventions to alter this trajectory.
